LKC Technologies
Português
Português English Español 日本
  • Produtos
    • For Humans
      • RETeval
      • UTAS mf/PERG
      • Tiras de sensor
    • For Animals
      • RETevet
      • Request Demo
      • Order Supplies
  • Aplicações
    • Testes e ERG
      • Electroretinography (ERG)
      • Potencial Evocado Visual (PEV)
    • Condições Clínicas
      • Retinopatia Diabética
      • Glaucoma
      • Retinal Ischemic Diseases
      • Inherited Retinal Disorders
      • Miscellaneous
    • Aplicações em animais
  • Recursos
    • Case Studies
    • eBooks & Reports
    • Webinars
    • Articles
    • Pesquisa
    • Blog
    • Videos
    • Software
  • Sobre a LKC
    • Vision & Mission
    • Team
    • Clinical Advisors
    • Depoimentos
    • História
  • Contato
  • Eye Care Customers
  • VET Customers
  • Buy Sensor Strips

Central Retinal Vein Occlusion (CRVO)

Show:

RETeval
Tiras de sensor
RETevet
Menu
  • Animal
  • Central Retinal Vein Occlusion
  • Retinopatia Diabética
  • Flicker ERG
  • Inherited Retinal Diseases
  • Optic Nerve Disorders
  • Pediatric
  • Photopic Negative Response
  • Tiras de sensor
Supernormal-Flicker-ERGs-in-Eyes-With-Central-Retinal-Vein-Occlusion-Clinical-Characteristics-Prognosis-and-Effects-of-Anti-VEGF-Agent

Supernormal Flicker ERGs in Eyes With Central Retinal Vein Occlusion: Clinical Characteristics, Prognosis, and Effects of Anti-VEGF Agent

Dezembro 1, 2018
The purpose of the study was to determine the clinical characteristics, prognosis, and effect of anti-vascular endothelial growth factor (VEGF)…
dovepress

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy

Maio 25, 2016
Author(s): Josh Wallsh, Behnam Sharareh, and Ron Gallemore, 2016. Publication: Clinical Ophthalmology Read Report here.
acta-ophth

Flicker electroretinograms before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion

Janeiro 18, 2015
Author(s): Yasuda, S., S. Kachi, S. Ueno, C. H. Piao, and H. Terasaki. 2015. Publication: Acta Ophthalmologica Scandinavica Foundation, 93(6):e465-8….
  • Produtos
    • RETeval
    • UTAS mf/PERG
    • Tiras de sensor
    • RETevet
  • Testes de Eletrofisiologia
    • Electroretinography (ERG)
    • ERG de campo completo (ffERG)
    • Padrão ERG (PERG)
    • ERG multifocal (mfERG)
    • Potencial Evocado Visual (PEV)
    • Endereço2 Professional Drive, Suite 222
      Gaithersburg, MD 20879 USA
    • Telefone+1 301 840 1992 (US & Canada)
      +358 40 8486625 (International)
    • DISTRIBUIDORES INTERNACIONAIS
      • Distribuidores de dispositivos médicos
      • Distribuidores de dispositivos veterinários
  • Follow LKC Technologies on LinkedIn
  • Follow LKC Technologies on Facebook
  • Subscribe to LKC Technologies on YouTube
  • Follow LKC Technologies on Instagram
cropped-cropped-LKC_logo_RGB_color_no_tagline_mini_400px.png
© 2025 LKC Technologies, Inc.
  • Accessibility Statement
  • Terms & Conditions
  • Certifications
  • Privacy Policy
  • Careers

California Proposition 65 information

Prop-65Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.

Substance Tables:

The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing. 

RETeval and RETevet Devices

Substance CAS # Type Listed as causing:
Nickel 7440-02-0 1 Cancer
Acrylonitrile 107-13-1 2
Ethylbenzine 100-41-4 2
Crystaline Silica 14808-60-7 1
Lead 7439-92-1 1 Cancer Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity
Methylene Chloride 75-09-2 2 Cancer Female Reproductive Toxicity
Bisphenol A 80-05-7 2
N-Hexane  110-54-3 2 Male Reproductive Toxicity